Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-21-002747
Accepted
2021-07-14 00:15:53
Documents
1
Effectiveness Date
2021-07-13
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 594
  Complete submission text file 9999999995-21-002747.txt   1831
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-257687 | Film No.: 211089208
SIC: 2834 Pharmaceutical Preparations